Corteva Inc. (CTVA)
Corteva: A 'Buy' On Constructive Growth And Margin Outlook
Corteva, Inc. is rated 'Buy', underpinned by robust growth and profitability levers. CTVA targets +3% annualized top-line expansion (FY26–29), outpacing the global crop protection sector, aided by past and future portfolio enhancements. CTVA is expected to deliver a cumulative 150bps EBITDA margin expansion and +6% EBITDA CAGR over the FY2026-FY2029 period, driven by cost reductions and a shift toward higher-margin biologicals.
AgTech & Food Innovation Stocks Driving Smarter Food Systems
TRMB, INGR and DE offer exposure to precision agriculture, food innovation and smarter farming technologies shaping the AgTech landscape.
Corteva remains a 'buy' as innovation offsets pressure on legacy products, BofA says
Bank of America (BofA) keeps its 'buy' rating on Corteva Inc (NYSE:CTVA) and sets an $18 price target, citing new product launches and tighter 2027 agriculture markets. Corteva, the US crop protection company, became a focused crop protection business on October 1, after separating its seed business into Vylor.
Corteva Just Split in Two. Here's What Shareholders Own Now
Corteva shareholders woke up to what looked like an 83% crash, but the real story is what they now own across two tickers and a lawsuit that could unwind the entire split.
What's happening with Corteva stock price today?
Corteva (CTVA) shares are undergoing a massive price adjustment on October 1st, plunging rather sharply after the market opened. While a glance at CTVA stock might look alarming, the crash isn't because of a sudden operational collapse or unexpected earnings miss.
Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole
Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole have been highlighted in this Industry Outlook article.
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers
CTVA's Q2 earnings beat and raised 2026 outlook signal progress, but Crop Protection pricing and separation risks remain.
Corteva Growth Improves, But Valuation Limits Upside
CTVA's stronger earnings outlook is supported by Seed growth and productivity gains, but Crop Protection pricing and separation risks persist.
Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript
Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript
Corteva Q2 Earnings Call Highlights
Corteva NYSE: CTVA raised its full-year outlook after reporting higher first-half sales, earnings and margins, citing demand for its seed technologies, growth in new crop-protection products, licensing income and cost discipline. The agricultural company also said it remains on schedule to separate its businesses on Oct. 1, with its advanced seed and genetics company expected to operate as Vylor.
Are You Looking for a Top Momentum Pick? Why Corteva, Inc. (CTVA) is a Great Choice
Does Corteva, Inc. (CTVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Corteva Q2 Earnings Beat Estimates, Sales Miss, '26 Outlook Raised
CTVA's Q2 EPS beats estimates as Seed pricing and productivity lift margins; sales fall 1% and the company raises its 2026 outlook.
